Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Cancer × apatinib × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Neoplasms 4 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 PD-L1 Positive Non-small Cell Lung Cancer 1 NSCLC 1 Metastatic Castration Resistant Prostate Cancer 1 Malignant Neoplasms of Digestive Organs 1 Fallopian Tube Neoplasms 1 Carcinoma, Adenoid Cystic 1 Advanced Cancer 1

Interventions

Nivolumab 13 linrodostat 5 Ipilimumab 5 relatlimab 3 Pemetrexed 3 Paclitaxel 3 Docetaxel 3 Carboplatin 3 regorafenib 2 abemaciclib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Gemcitabine 2 Capecitabine 2 ARRY-334543 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 trametinib 1 tislelizumab 1 sargramostim 1 ralimetinib 1 palifosfamide lysine 1 p38 Mitogen-Activated Protein Kinases 1 lirilumab 1 fluzoparib 1 fluorapacin 1 etirinotecan pegol 1 emibetuzumab 1 efatutazone 1 cemiplimab 1 bempegaldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03243643 2017-09-08

HS:Hansoh;

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase 1 Unknown

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡